FILING ANALYSIS · WEDNESDAY, OCTOBER 28
Axogen, Inc. AXGN — 8-K: Results of Operations and Financial Condition
neutral
Axogen, Inc. reported strong Q3 2026 financial results, with revenue growth of 26.2% and raised full-year revenue guidance to at least 29% growth or $290 million, driven by broad-based growth across all markets and the recent acquisition of BioCircuit Technologies, but also announced an upsized public offering that may lead to dilution
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →